Igrene reported a net loss of -5.2 MSEK and high equity ratio, focusing on emission-free hydrogen and carbon production from biogenic methane. A successful rights issue raised 13.2 MSEK, and future operations hinge on regulatory approvals and EU funding.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.